Results

Total Results: 951 records

Showing results for "death".

261. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
     May 19, 2020 - 6 • Discomfort or distress from equipment, e.g., oxygen or masks • Death … Urinary retention, dry mouth • Opioid use disorder • Discomfort or distress from equipment, • Death

262. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
     December 31, 2022 - Omicron variant (43–56%) but was more protective against severe disease (88%), hospitalization (47%), or death … by 45 percent (hazard ratio [HR]=0.55; 95% CI: 0.48, 0.63) and reduced the risk of COVID-19 related death … individuals, prior infection had no effect on the risk of hospitalization but reduced the risk of death … immune protection persisted, as indicated by the relatively low incidence of serious infection and death … Comparative analysis of the risks of hospitalisation and death associated with SARS- CoV-2 omicron (

263. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
     February 07, 2025 - repair-deficient [MMR-deficient], claudin, human epidermal growth factor receptor 2 [HER-2], programmed death-ligand … immunotherap* OR 'immuno-therap*' OR 'microsatellite instability' OR 'mismatch repair' OR 'programmed cell death … ' OR 'programmed death ligand' OR 'radio-immuno*' OR radioimmuno*) OR (atezolizumab OR ipilimumab OR

264. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - Other outcomes of interest were quality of life and sudden death. … of planned followup found celecoxib associated with an increased risk of cardiovascular events (CV death … results with regard to CV events (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death … failure, one large observational study found celecoxib and diclofenac associated with a higher risk of death

265. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - Rosuvastatin  Simvastatin • Outcomes o Clinical outcomes:  All-cause mortality and vascular death … the study investigator  SAEs as defined by the study investigator (e.g., an event that results in death … Outcomes Clinical outcomes • All-cause mortality • Vascular death • Fatal MI, nonfatal MI, any or … independently grade the strength of evidence on key outcomes—including, all-cause mortality, vascular death

266. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
     January 01, 2024 - repair-deficient [MMR-deficient], claudin, human epidermal growth factor receptor 2 [HER-2], programmed death-ligand … immunotherap* OR 'immuno-therap*' OR 'microsatellite instability' OR 'mismatch repair' OR 'programmed cell death … ' OR 'programmed death ligand' OR 'radio-immuno*' OR radioimmuno*) OR (atezolizumab OR ipilimumab OR

267. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - ultimate goal in preventing preterm birth is to eliminate the risks of neonatal complications and death … In these same trials, the risk of neonatal death was 4.0 percent among women in the placebo group and

268. Maternal Morbidity and Mortality | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/maternal-morbidity-mortality/protocol

269. Protocol Amendment - Safety of Vaccines 030413 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
     September 18, 2012 - other parental concerns about childhood vaccines include links to multiple sclerosis, sudden infant death … self-care ADL Grade 4: Life-threatening consequences; urgent intervention indicated Grade 5: Death … 25, 2013 Adverse event Vaccine type Constipation Below severity threshold Crohn’s disease MMR Death

270. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - In addition, the death rate from cardiovascular disease in adults with type 2 diabetes is two to four

271. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - 40% of all kidney cancers.[6, 7] Interestingly, despite this increase in early-stage cancers, the death … management or medications only § Major: requiring intervention, resulting in permanent disability or death … management or medications only o Major: requiring intervention, resulting in permanent disability or death

272. Effectiveness of Indoor Allergen Reduction in Management of Asthma - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-reduction-asthma-evidence-summary.pdf
     February 01, 2018 - • Exacerbations • Health care utilization and cost • Pulmonary physiology • Quality of life • Death

273. Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
     May 31, 2017 - Background and Rationale In 2014, unintentional injury was the fourth leading cause of death in the … time of field triage cannot be determined conclusively and we expect that clinical outcomes (e.g., death … These include outcomes, such as death, whether the patient required treatments and interventions used … pericardiocentesis, cesarean delivery, intracranial pressure monitoring, interventional radiology, and in-hospital death

274. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - insufficient • BB significantly reduced risk of all-cause mortality, CHF hospitalizations, and CHF death

275. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
     August 08, 2017 - rate ratio (95% CI) Nonfatal MI: 1.71 (1.23 to 2.37) Nonfatal stroke: 1.04 (0.73 to 1.49) Coronary death … rate ratio (95% CI) Nonfatal MI: 1.09 (0.87 to 1.36) Nonfatal stroke: 0.86 (0.65 to 1.15) Coronary death … rate ratio (95% CI) Nonfatal MI: 2.02 (1.35 to 3.02) Nonfatal stroke: 1.19 (0.76 to 1.86) Coronary death … adverse events Note: major vascular events include nonfatal myocardial infarction, nonfatal stroke, or death

276. Surveillance & Identification of Triggers for Updating Systematic Reviews for the EHC Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
     August 01, 2012 - ) 44 (45) vs. 92 (65); p=0.02 Mucositis (RTOG Grade 3–4) 73 (75%) vs. 111 (77%); p= 0.33 Death … In other words the reduction in the risk of death has moved from 30% to 10%. … ratios (e.g., if previous OR=0.70 and updated result were OR=0.90, then the new reduction in odds of death … 3–4) 44 (45) vs. 92 (65); p=0.02 Mucositis (RTOG Grade 3–4) 73 (75%) vs. 111 (77%); p= 0.33 Death

277. Executive Summary_Comparative Effectiveness Review No. 269: Respectful Maternity Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
     January 01, 2024 - page 2) 2 Background and Purpose Severe maternal morbidity and death

278. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
     January 01, 2013 - overall disease burden expressed as the number of years lost to poor health, disability, or premature death … Potential years of life lost to premature death are supplemented with years of healthy life lost due … Failure to account for missing PRO data that are related to poor health or death will lead to an overestimate

279. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
     April 01, 2007 - records systems, institutional or organizational databases, administrative health insurance claims data, death … information on individual identifiers to permit linkage with external databases such as the National Death … • Results that can be confirmed by an unbiased observer—such as death, test results, and scores from

280. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
     October 08, 2014 - to improve; a recent analysis of more than 250,000 kidney transplant recipients demonstrated that death-censored … and the development of metabolic syndrome, which are significant concerns because the main cause of death … living (related or non-related) or deceased donor renal transplant (brain dead donors, donors after cardiac … death, and expanded criteria donors.) … type (living donor or deceased donor; for deceased donors: expanded criteria donors, donation after cardiac